Greene M - Search Results

1

Rational Design of Constrained Peptides as Protein Interface Inhibitors.

Murali R, Zhang H, Cai Z, Lam L, Greene M. Murali R, et al. Among authors: greene m. Antibodies (Basel). 2021 Aug 16;10(3):32. doi: 10.3390/antib10030032. Antibodies (Basel). 2021. PMID: 34449551 Free PMC article. Review.

2

Study of disabling T-cell activation and inhibiting T-cell-mediated immunopathology reveals a possible inverse agonist activity of CD4 peptidomimetics.

Horie T, Shen Y, Kajino K, Gaubin M, Bonomi G, Mani JC, Berezov A, Piatier-Tonneau D, Guardiola J, Hillard B, Rostami A, Greene M, Murali R. Horie T, et al. Among authors: greene m. Exp Mol Pathol. 2002 Oct;73(2):93-103. doi: 10.1006/exmp.2002.2444. Exp Mol Pathol. 2002. PMID: 12231211

3

Modulation of ultralarge immune complexes in heparin-induced thrombocytopenia.

Cai Z, Bdeir K, Yarovoi SV, Rauova L, Arepally GM, Khandelwal S, Rollin J, Gruel Y, Zaitsev S, Poncz M, Greene MI, Cines DB. Cai Z, et al. Among authors: greene mi. J Thromb Haemost. 2023 Mar;21(3):652-666. doi: 10.1016/j.jtha.2022.11.043. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696211 Free article.

4

Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer.

Goel PN, Zhang H, Murali R, Zheng C, Ji MQ, Patterson A, Grover P, Greene M. Goel PN, et al. Among authors: greene m. Biochem Biophys Res Commun. 2023 Apr 9;651:39-46. doi: 10.1016/j.bbrc.2023.02.019. Epub 2023 Feb 9. Biochem Biophys Res Commun. 2023. PMID: 36791497

5

HED, a Human-Engineered Domain, Confers a Unique Fc-Binding Activity to Produce a New Class of Humanized Antibody-like Molecules.

Zhu Z, Goel PN, Zheng C, Nagai Y, Lam L, Samanta A, Ji M, Zhang H, Greene MI. Zhu Z, et al. Among authors: greene mi. Int J Mol Sci. 2023 Mar 30;24(7):6477. doi: 10.3390/ijms24076477. Int J Mol Sci. 2023. PMID: 37047449 Free PMC article.

6

neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer.

Jardines L, Weiss M, Fowble B, Greene M. Jardines L, et al. Among authors: greene m. Pathobiology. 1993;61(5-6):268-82. doi: 10.1159/000163805. Pathobiology. 1993. PMID: 7905269 Review.

7

Survivin as a Therapeutic Target for the Treatment of Human Cancer.

Wang Q, Greene MI. Wang Q, et al. Among authors: greene mi. Cancers (Basel). 2024 Apr 27;16(9):1705. doi: 10.3390/cancers16091705. Cancers (Basel). 2024. PMID: 38730657 Free PMC article. Review.

8

Peter C. Nowell (1928-2016).

Greene MI, Moore JS. Greene MI, et al. Science. 2017 Mar 3;355(6328):913. doi: 10.1126/science.aam9738. Science. 2017. PMID: 28254903 No abstract available.

9

F77 antigen is a promising target for adoptive T cell therapy of prostate cancer.

Grover P, Nunez-Cruz S, Leferovich J, Wentz T, Bagchi A, Milone MC, Greene MI. Grover P, et al. Biochem Biophys Res Commun. 2023 Nov 5;680:51-60. doi: 10.1016/j.bbrc.2023.09.018. Epub 2023 Sep 12. Biochem Biophys Res Commun. 2023. PMID: 37717341 Free article.

10

The neu gene in 4 human neuroblastoma cell lines.

Maguire HC Jr, Sibinga E, Weiner D, Greene M. Maguire HC Jr, et al. Among authors: greene m. Prog Clin Biol Res. 1988;271:165-73. Prog Clin Biol Res. 1988. PMID: 3405999 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,988 results

Search Page